Delivery Order SPE2DB20D9127-SPE2DB24FPPB7

Award Date 10/18/23
Potential Completion Date 10/19/23
Potential Value $73K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $111,160.98, is for the delivery of Trikafta, a specialty pharmaceutical product, with a period of performance through September 30, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,633.14 contract is for the delivery of Trikafta 100-50-75 mg/75 mg pharmaceutical product, with a completion date of January 21, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $19,314.19, is for the delivery of the pharmaceutical product Trikafta with a completion date of January 14, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This delivery order, valued at $37,053.68, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the delivery of Trikafta, a specialty pharmaceutical product, and is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA. The IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $37,053.66, is for the delivery of Trikafta, a specialized prescription medication, and has a completion date of September 18, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $37,053.66, is for the delivery of the pharmaceutical product Trikafta 50-25-37.5 mg/75 mg. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $76,830.55, is for the delivery of Trikafta, a specialized prescription medication. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $226,462.55 and an ultimate completion date of March 26, 2025. The award is for the provision of Trikafta, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is part of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,526.83, is for the delivery of the pharmaceutical product Trikafta 100-50-75 mg/150 mg. The contract has a completion date of July 2, 2024 and does not have a set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC)...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB24FPPB7
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $73,275.04 contract is for the delivery of Trikafta, a specialty pharmaceutical product, with an ultimate completion date of October 19, 2023.

DMS Pharmaceutical Group Inc. holds a large indefinite delivery contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. This specific delivery order is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across various medical product categories.

Generated 2/27/25, 12:05 PM